Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01587365 · ClinicalTrials.gov registry record · Phase 1
Single Ascending Dose Safety Study of BMS-962476 in Healthy Subjects and Patients With Elevated Cholesterol on Statins
A Phase 1 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 1
- Development phase
- 66
- Enrollment target
NCT01587365: Completed Phase 1 study, sponsored by Bristol-Myers Squibb.
NCT01587365 is a Phase 1 study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 66 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (10% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01587365, a Phase 1 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 66 participants
- Enrollment target
Study Summary
To obtain safety and tolerability information in healthy subjects is administered as a single dose
Interventions
- BIOLOGICAL BMS-962476
- BIOLOGICAL Placebo matching with BMS-962476
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-05 |
| Phase | Phase 1 |
What the finished NCT01587365 record still lists
NCT01587365 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (10% higher).
The record links to 0 conditions, and to 2 interventions - of which BMS-962476 is the first listed.
NCT01587365 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01587365 about?
NCT01587365 is a clinical study titled "Single Ascending Dose Safety Study of BMS-962476 in Healthy Subjects and Patients With Elevated Cholesterol on Statins". To obtain safety and tolerability information in healthy subjects is administered as a single dose
What is the current status of trial NCT01587365?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 66 participants. The study started on 2012-05. Estimated completion is 2013-05.
What interventions are being tested in trial NCT01587365?
The interventions under investigation include: BMS-962476 (BIOLOGICAL), Placebo matching with BMS-962476 (BIOLOGICAL).
Who is sponsoring clinical trial NCT01587365?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01587365's enrollment target sits among peer trials
66 786th of 2000 higher than 1,203 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia